1. Home
  2. LIDR vs ICCC Comparison

LIDR vs ICCC Comparison

Compare LIDR & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AEye Inc.

LIDR

AEye Inc.

HOLD

Current Price

$2.18

Market Cap

69.8M

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$8.34

Market Cap

64.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LIDR
ICCC
Founded
2013
1982
Country
United States
United States
Employees
45
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.8M
64.0M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
LIDR
ICCC
Price
$2.18
$8.34
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.75
N/A
AVG Volume (30 Days)
5.6M
25.7K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
53.85
EPS
N/A
N/A
Revenue
N/A
$26,493,169.00
Revenue This Year
$2,604.29
N/A
Revenue Next Year
$466.58
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
51.64
52 Week Low
$0.50
$4.52
52 Week High
$6.44
$8.46

Technical Indicators

Market Signals
Indicator
LIDR
ICCC
Relative Strength Index (RSI) 66.10 72.90
Support Level $1.50 $5.78
Resistance Level $2.39 N/A
Average True Range (ATR) 0.16 0.34
MACD 0.03 0.10
Stochastic Oscillator 46.07 94.94

Price Performance

Historical Comparison
LIDR
ICCC

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: